Intervention

APL 400-047

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

2 shown

A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult VolunteersNCT00001088 · 1997-07-01

A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected VolunteersNCT00001090

Common conditions

HIV Infections2

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)2

Trial status mix

COMPLETED2

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.